IQVIA highlights its collaboration with PharmaCCX in Finland to address complex oncology pricing caused by multi-indication and combination treatments. PharmaCCX’s digital tool enables live negotiations, rebate settlements, and simulation of contracting models. With versions like the CCX Terminal for real deals and a Sandbox for training, the platform reduces administrative burdens and supports innovative reimbursement frameworks. By integrating consumption data at the indication/combination level, stakeholders can negotiate differentiated pricing and monitor real-world outcomes. This solution supports payers and pharma in piloting flexible pricing models, ensuring efficiency, and meeting the demands of increasingly complex oncology treatments.

Join for free to read